Zobrazeno 1 - 10
of 73
pro vyhledávání: '"Hideyuki Yamato"'
Autor:
Junichiro James Kazama, Masafumi Fukagawa, Ryosuke Ozasa, Takayoshi Nakano, Shingo Fukuma, Suguru Yamamoto, Akemi Ito, Shin Goto, Shunichi Fukuhara, Yoshihiro Onishi, Takuya Wakamatsu, Koji Matsuo, Hideyuki Yamato, Chisato Miyakoshi, Tadao Akizawa, Ichiei Narita, Yoshiko Iwasaki, Kennichi Tanaka
Publikováno v:
Journal of Bone and Mineral Research. 36(1):67-79
Wakamatsu T., Iwasaki Y., Yamamoto S., et al. Type I Angiotensin II Receptor Blockade Reduces Uremia-Induced Deterioration of Bone Material Properties. Journal of Bone and Mineral Research, 36, 1, 67. https://doi.org/10.1002/jbmr.4159.
Chronic k
Chronic k
Autor:
Ichiei Narita, Yoshiko Iwasaki, Hideyuki Yamato, Koji Matsuo, Suguru Yamamoto, Chisato Miyakoshi, Akemi Ito, Shin Goto, Kennichi Tanaka, Ryosuke Ozasa, Shingo Fukuma, Takayoshi Nakano, Shunichi Fukuhara, Masafumi Fukagawa, Tadao Akizawa, Takuya Wakamatsu, Yoshihiro Onishi, Junichiro J. Kazama
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f88b0dee2c75cd964e0c2e10644401a9
https://doi.org/10.1002/jbmr.4159/v4/response1
https://doi.org/10.1002/jbmr.4159/v4/response1
Publikováno v:
Uremic Toxins and Organ Failure ISBN: 9789811577925
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0c49ba7a3dabeb7a9c10e45803edf3d4
https://doi.org/10.1007/978-981-15-7793-2_7
https://doi.org/10.1007/978-981-15-7793-2_7
Autor:
Takuya Matsumoto, Masahiro Okada, Yu Ki Tanaka, Hideyuki Yamato, Yusuke Higuchi, Takafumi Hirata, Shigeaki Miyazaki, Nobuyuki Yajima
Publikováno v:
The Analyst. 142:4265-4278
We investigated the possible linkage between the crystallinity and elemental ratios (Mg/Ca and Sr/Ca) of the femoral cortical bones of rats with chronic kidney disease (CKD) or diabetes mellitus (DM). The Mg/Ca and Sr/Ca ratios were measured by using
Autor:
Naoto Hamano, Masafumi Fukagawa, Takehiko Wada, Michio Nakamura, Hirotaka Komaba, Hideyuki Yamato, Kaichiro Sawada, Hiroaki Ishida
Publikováno v:
Journal of bone and mineral metabolism. 38(4)
High-turnover bone disease is a major consequence of SHPT and may explain the high risk for fracture in patients with advanced chronic kidney disease (CKD). Bisphosphonates suppress bone turnover and improve bone strength, but their effects have not
Autor:
Kaichiro Sawada, Naoto Hamano, Hideyuki Yamato, Yosuke Nakagawa, Hiroaki Ishida, Masafumi Fukagawa, Michio Nakamura, Hirotaka Komaba, Takehiko Wada
Publikováno v:
Nephrology Dialysis Transplantation. 34
Autor:
Yoshiaki Tanaka, Matsumoto Kazuko, Hideyuki Yamato, Ryutaro Wada, Seishiro Kakimoto, Tadamasa Fujimura, Yamashita Takeshi, Masakazu Akita
Publikováno v:
Scientific Reports
Scientific Reports, Vol 8, Iss 1, Pp 1-14 (2018)
Scientific Reports, Vol 8, Iss 1, Pp 1-14 (2018)
A new adsorbent Cu-Perussian blue@Nanodiamond (Cu-PB@DND) for Cs+ removal was prepared and characterized with IR, SEM, X-ray diffraction, particle size analysis, and zeta-potential. The adsorbent consists of a core of aggregated detonation nanodiamon
Publikováno v:
Metallomics : integrated biometal science. 9(12)
Herein, we measure the Ca isotope ratios (44Ca/42Ca and 43Ca/42Ca) in serum and bone samples collected from rats with chronic kidney disease (CKD) or diabetes mellitus (DM). For the serum samples, the isotope ratios are lower for the CKD (δ44Ca/42Ca
Autor:
Naomi Omi, Takayuki Akimoto, Yuki Aikawa, Hideyuki Yamato, Ikuko Ezawa, Jong Hoon Park, Umon Agata, Michito Higano, Masaya Oda, Satoshi Hattori, Yoshiharu Nabekura
Publikováno v:
Journal of Nutritional Science and Vitaminology. 60:35-42
The pathogenesis of bone disorders in young male athletes has not been well understood. We hypothesized that bone fragility is caused by low energy availability, due to insufficient food intake and excessive exercise energy expenditure in young male
Autor:
Hideyuki Yamato, Yoshitaka Mori, Hisae Tanaka, Masafumi Fukagawa, Hiroshi Watanabe, Toru Maruyama, Yoshiko Iwasaki, Hirotaka Komaba
Publikováno v:
Bone. 56:347-354
Recent data suggest that several uremic toxins may contribute to the development of bone abnormalities in chronic kidney disease. p-Cresyl sulfate (PCS), the sulfate conjugate of p-cresol, is a protein-bound uremic toxin associated with the progressi